Flow-enhanced electrochemical aptamer sensor for nanomolar detection of NGAL in blood plasma for kidney injury diagnosis
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.118906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Anagha Chandran und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh, 4-5 Little France Dr, Edinburgh, EH16 4UU, UK. …. Hauptthemen laut MEDLINE: Lipocalin-2, Biosensing Techniques, Acute Kidney Injury, Aptamers, Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline, Engineering and Physical Sciences Research Council, Johnson Matthey plc.
Abstract (Originalsprache)
Early detection of Acute Kidney Injury (AKI) remains a clinical challenge, requiring rapid and sensitive monitoring of biomarkers like Neutrophil Gelatinase-Associated Lipocalin (NGAL). This study presents a flow-enhanced electrochemical aptamer-based (E-AB) biosensor designed for the nanomolar detection of NGAL in complex matrices. By integrating optimised hydrodynamic flow (35 μL/min) with miniaturised gold microelectrodes, we leveraged enhanced mass transport and radial diffusion to significantly improve analyte flux and binding kinetics. A critical finding was the role of the protein matrix in surface passivation; the inclusion of 4% BSA resulted in a >20-fold sensitivity improvement compared to standard PBS buffer, attributed to additional passivation during measurement. This synergistic approach enabled a limit of detection (LOD) of 0.2 nM with a dynamic range spanning 0.2-24 nM. As a preliminary proof-of-concept, the clinical utility was validated using unprocessed human plasma samples from AKI patients, demonstrating a moderate correlation (R2 = 0.7731) with gold-standard ELISA measurements and accuracy in clinical risk stratification. These results highlight the potential of flow-enhanced E-AB sensors for continuous, near-real-time monitoring of critical biomarkers in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh, 4-5 Little France Dr, Edinburgh, EH16 4UU, UK. Electronic address: A.Chandran@sms.ac.uk.
- Johnson Matthey, Blounts Court, Sonning Common, Reading, RG4 9NH, UK. Electronic address: ross.gordon@matthey.com.
- Centre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh, 4-5 Little France Dr, Edinburgh, EH16 4UU, UK. Electronic address: Jonathan.Fallowfield@ed.ac.uk.
- Centre for Inflammation Research, Institute for Regeneration and Repair, The University of Edinburgh, 4-5 Little France Dr, Edinburgh, EH16 4UU, UK. Electronic address: Till.Bachmann@ed.ac.uk.
Förderung
- GlaxoSmithKline
- Engineering and Physical Sciences Research Council
- Johnson Matthey plc
- Genentech
Zitieren
APA
Chandran, A., Gordon, R., Fallowfield, J. A., & Bachmann, T. T. (2026). Flow-enhanced electrochemical aptamer sensor for nanomolar detection of NGAL in blood plasma for kidney injury diagnosis. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.118906
Vancouver
Chandran A, Gordon R, Fallowfield JA, Bachmann TT. Flow-enhanced electrochemical aptamer sensor for nanomolar detection of NGAL in blood plasma for kidney injury diagnosis. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.118906
BibTeX
@article{Chandran2026,
author = {Chandran, Anagha and Gordon, Ross and Fallowfield, Jonathan A and Bachmann, Till T},
title = {Flow-enhanced electrochemical aptamer sensor for nanomolar detection of NGAL in blood plasma for kidney injury diagnosis},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.118906}
}
EUVIMED